https://www.axolabs.com/about/
CRO and CDMO solutions for Oligos and Nucleic Acid Therapeutics - Axolabs
Apr 9, 2026 - Discover why Axolabs is the leading CRO and CDMO for nucleic acid therapeutics for nucleic acid therapeutics services.
nucleic acid therapeuticscdmo solutionscrooligosaxolabs
https://www.businesswire.com/news/home/20240411168939/en/Asahi-Kasei-Bioprocess-and-Axolabs-Announce-Strategic-Partnership-to-Accelerate-Oligonucleotide-Therapeutics-Development
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide...
Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
asahi kaseistrategic partnershipbioprocessaxolabs